Search for instruments
Deciphera Pharmaceuticals Inc
Deciphera Pharmaceuticals Inc is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapies for cancer treatment. The company's proprietary platform technology allows for the identification of novel kinase inhibitors that selectively target cancer cells while sparing healthy cells. Ripretinib, Deciphera's lead product candidate, is a kinase inhibitor being developed for the treatment of gastrointestinal stromal tumors (GIST) and other solid tumors. The company is also developing a pipeline of other kinase inhibitors for various cancer treatments. Deciphera is committed to advancing its innovative therapies through clinical development and regulatory approval to improve the lives of cancer patients.Instrument specification in OANDA
Name
Deciphera Pharmaceuticals Inc
Currency
USD
Symbol
DCPH.US
Minimum order value
1
Ticker
DCPH
Trading hours
monday-friday 15:30-22:00
Type
Stocks US
Hours of accepting orders
monday-friday 11:00-22:00
ISIN
US24344T1016
Start trading now with fast account opening.
Sign-up now to trade the most active markets
Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
